Maternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 34, Issue 49, 2016, Pages 6077-6083

  Patwardhan, M ^a   Eckert, L O ^b   Spiegel, H ^c   Pourmalek, F ^d   Cutland, C ^e   Kochhar, S ^f   Gonik, B ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Henry Jackson Foundation   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f Healthcare Management Consultants   (India)

Author keywords

Adverse event; Immunization; Maternal death; Vaccination

Indexed keywords

VACCINE;

ARTICLE; CAUSE OF DEATH; DATA ANALYSIS; DISEASE CLASSIFICATION; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; INFORMATION PROCESSING; MATERNAL DEATH; MEDICAL HISTORY; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; VACCINATION; VACCINATION REACTION; DRUG SURVEILLANCE PROGRAM; IMMUNIZATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; FEMALE; GUIDELINES AS TOPIC; HUMANS; IMMUNIZATION; MATERNAL DEATH; PREGNANCY; VACCINES;

EID: 84999792394     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.042     Document Type: Article

References (23)

1. [1] Kassebaum, N.J., Bertozzi-Villa, A., Coggeshall, M.S., Shackelford, K.A., Steiner, C., Heuton, K.R., et al. Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 980–1004.
2. [2] Centers for Disease C, Prevention. Maternal mortality – United States, 1982–1996. Morb Mortal Wkly Rep 47 (1998), 705–707.
3. [3] Patel, Maternal health epidemiology. CDC, 2003.
4. [4] Hanson, M.A., Gluckman, P.D., Developmental origins of health and disease – global public health implications. Best Pract Res Clin Obstet Gynaecol 29 (2015), 24–31.
5. [5] Brolan, C.E., Hill, P.S., Countdown for health to the post-2015 UN Sustainable Development Goals. Med J Aust 202 (2015), 289–290.
6. [6] Pazos, M., Sperling, R.S., Moran, T.M., Kraus, T.A., The influence of pregnancy on systemic immunity. Immunol Res 54 (2012), 254–261.
7. [7] Bhalerao-Gandhi, A., Chhabra, P., Arya, S., Simmerman, J.M., Influenza and pregnancy: a review of the literature from India. Infect Dis Obstet Gynecol, 2015, 2015, 867587.
8. [8] Meijer, W.J., van Noortwijk, A.G., Bruinse, H.W., Wensing, A.M., Influenza virus infection in pregnancy: a review. Acta Obstet Gynecol Scand 94 (2015), 797–819.
9. [9] Collet, J.P., MacDonald, N., Cashman, N., Pless, R., Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee Advisory Committee on Causality Assessment. Bull World Health Organ 78 (2000), 178–185.
10. [10] Stratton, K., Ford, A., Rusch, E., Clayton, E.W., (eds.) Adverse effects of vaccines: evidence and causality, Washington, DC, 2011.
11. [11] Christian, L.M., Iams, J.D., Porter, K., Glaser, R., Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 29 (2011), 8982–8987.
12. [12] Datwani, H., Moro, P.L., Harrington, T., Broder, K.R., Chorioamnionitis following vaccination in the Vaccine Adverse Event Reporting System. Vaccine 33 (2015), 3110–3113.
13. [13] Orenstein, L.A., Orenstein, E.W., Teguete, I., Kodio, M., Tapia, M., Sow, S.O., et al. Background rates of adverse pregnancy outcomes for assessing the safety of maternal vaccine trials in sub-Saharan Africa. PLOS ONE, 7, 2012, e46638.
14. [14] Mantel, G.D., Buchmann, E., Rees, H., Pattinson, R.C., Severe acute maternal morbidity: a pilot study of a definition for a near-miss. Br J Obstet Gynaecol 105 (1998), 985–990.
15. [15] Filippi, V., Ronsmans, C., Gohou, V., Goufodji, S., Lardi, M., Sahel, A., et al. Maternity wards or emergency obstetric rooms? Incidence of near-miss events in African hospitals. Acta Obstet Gynecol Scand 84 (2005), 11–16.
16. [16] Kaye, D.K., Kakaire, O., Osinde, M.O., Systematic review of the magnitude and case fatality ratio for severe maternal morbidity in sub-Saharan Africa between 1995 and 2010. BMC Pregnancy Childbirth, 11, 2011, 65.
17. [17] Gulmezoglu, A.M., Say, L., Betran, A.P., Villar, J., Piaggio, G., WHO systematic review of maternal mortality and morbidity: methodological issues and challenges. BMC Med Res Methodol, 4, 2004, 16.
18. [18] Zheteyeva, Y., Moro, P.L., Yue, X., Broder, K., Safety of meningococcal polysaccharide-protein conjugate vaccine in pregnancy: a review of the Vaccine Adverse Event Reporting System. Am J Obstet Gynecol, 208, 2013 478(e1–6).
19. [19] Zheteyeva, Y.A., Moro, P.L., Tepper, N.K., Rasmussen, S.A., Barash, F.E., Revzina, N.V., et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol, 207, 2012 59(e1–7).
20. [20] Nokleby, H., Vaccination and anaphylaxis. Curr Allergy Asthma Rep 6 (2006), 9–13.
21. [21] Unsworth, D.J., Tsiougkos, N., Improving detection and management of drug allergy. Practitioner 259 (2015), 25–27 3.
22. [22] Romano, A., Caubet, J.C., Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. J Allergy Clin Immunol Pract 2 (2014), 3–12.
23. [23] Drug Allergy: Diagnosis and Management of Drug Allergy in Adults, Children and Young People, London. 2014.